Edward L. Michael - 25 Jun 2026 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
29 Jun 2026, 17:58:34 UTC
Prior SEC filing
09 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Phillip S. Askim, attorney-in-fact for Edward L. Michael

Key filing fact

Edward L. Michael filed Form 4 for QuidelOrtho Corp (QDEL) on 29 Jun 2026.

Key facts

  • This page summarizes Edward L. Michael's Form 4 filing for QuidelOrtho Corp (QDEL).
  • 3 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 29 Jun 2026, 17:58.

Change

  • Previous filing in this sequence was filed on 09 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001391823 Primary reporting owner

Michael Edward L.

Relationship
Director
Address
9975 SUMMERS RIDGE ROAD, SAN DIEGO
Signature
/s/ Phillip S. Askim, attorney-in-fact for Edward L. Michael
Signature date
29 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QDEL transaction Derivative

Restricted Stock Units (Equity Grant)

Award

Transaction value
Shares
+15,532
Change %
Price
$0.000000*
Shares after
15,532
Date
25 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,532
Exercise price
Footnotes
F1, F2
QDEL transaction Derivative

Restricted Stock Units (Converted)

Award

Transaction value
Shares
+3,513
Change %
Price
$0.000000*
Shares after
3,513
Date
25 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,513
Exercise price
Footnotes
F1, F3, F4
QDEL transaction Derivative

Restricted Stock Units (Premium)

Award

Transaction value
Shares
+1,053
Change %
Price
$0.000000*
Shares after
1,053
Date
25 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,053
Exercise price
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

Footnote F2

The restricted stock units will vest on June 25, 2027.

Footnote F3

The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.

Footnote F4

878 shares vested on June 25, 2026, 878 shares will vest on September 25, 2026, 878 shares will vest on December 25, 2026, and 879 shares will vest on March 25, 2027.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .